[1]
O. K. Farat, S. A. Varenychenko, and V. I. Markov, “Prediction of biological activity of spiroquinazolone derivatives as protein kinase inhibitors FGFR1 and CK2”, Current issues in pharmacy and medicine: science and practice, vol. 13, no. 1, Mar. 2020.